Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcutis Biotherapeutics (ARQT) Tax Provisions (2023 - 2025)

Arcutis Biotherapeutics (ARQT) has 3 years of Tax Provisions data on record, last reported at $499000.0 in Q4 2025.

  • For Q4 2025, Tax Provisions rose 80.8% year-over-year to $499000.0; the TTM value through Dec 2025 reached $1.2 million, up 100.0%, while the annual FY2025 figure was $1.2 million, 100.0% up from the prior year.
  • Tax Provisions reached $499000.0 in Q4 2025 per ARQT's latest filing, up from $80000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $3.1 million in Q3 2023 and bottomed at $25000.0 in Q4 2023.
  • Average Tax Provisions over 3 years is $614125.0, with a median of $301500.0 recorded in 2024.
  • Peak YoY movement for Tax Provisions: skyrocketed 1004.0% in 2024, then decreased 13.89% in 2025.
  • A 3-year view of Tax Provisions shows it stood at $25000.0 in 2023, then surged by 1004.0% to $276000.0 in 2024, then soared by 80.8% to $499000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Tax Provisions were $499000.0 in Q4 2025, $80000.0 in Q3 2025, and $342000.0 in Q2 2025.